Skip to main content
Year archive

4SC AG — 2018 filings

All 39 regulatory filings released by 4SC AG (VSC) in 2018, sourced directly from the official regulator.

39 Filings
2018 Period
2018 filings (39)
Filing Released Lang
4SC AG: Positive safety review of 4SC's Phase Ib/II SENSITIZE study of domatinostat (4SC-202) + pembrolizumab in melanoma
Regulatory Filings
2018-12-27 English
4SC reaches significant milestone with enrollment of 100 patients in pivotal RESMAIN study of resminostat as CTCL maintenance therapy
Regulatory Filings
2018-11-20 English
4SC receives milestone payment from Link Health
Regulatory Filings
2018-10-31 English
Report Publication Announcement 2018
Report Publication Announcement
2018-10-26 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2019 bis zum 30.06.2019
Report Publication Announcement
2018-10-26 German
Datum:26.10.2018
Report Publication Announcement
2018-10-26 German
4SC provides Q3 business update and outlook
Earnings Release Q3 2018
2018-10-25 English
Q3 statement / Q3 financial report 2018
Management Reports
2018-10-25 English
4SC AG: Domatinostat plus chemotherapy - Overcoming drug resistance
Environmental & Social Information
2018-09-20 English
Halbjahresbericht zum 30. Juni 2018
Interim / Quarterly Report H1 2018
2018-09-19 German
4SC AG: 6 upcoming conferences and roadshows
Regulatory Filings
2018-09-12 English
4SC AG: FDA approves IND application for domatinostat (4SC-202) in melanoma
Regulatory Filings
2018-08-15 English
Half-yearly financial report 2018
Interim / Quarterly Report H1 2018
2018-08-10 English
4SC provides Q2 and H1 2018 update
Earnings Release H1 2018
2018-08-09 English
4SC AG: Conference call to be hosted on 9 August 2018 to present the half-year report 2018
Report Publication Announcement
2018-08-02 English
First patient enrolled in 2nd dose cohort of Phase Ib/II study SENSITIZE of domatinostat (4SC-202) + pembrolizumab in melanoma
Regulatory Filings
2018-07-31 English
4SC AG: Stifel Nicolaus Europe initiates research coverage on 4SC with a buy rating
Regulatory Filings
2018-07-18 English
4SC AG: Positive safety review of 4SC's Phase Ib/II SENSITIZE study of domatinostat (4SC-202) + pembrolizumab in melanoma
Regulatory Filings
2018-07-03 English
4SC AG: New data supports resminostat's mechanism of action in CTCL maintenance therapy
Regulatory Filings
2018-06-28 English
4SC AG: 9 upcoming conferences and roadshows
Report Publication Announcement
2018-05-22 English
Q1 statement / Q1 financial report 2018
Interim / Quarterly Report Q1 2018
2018-04-27 English
4SC provides Q1 2018 update
Earnings Release Q1 2018
2018-04-26 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2017 bis zum 31.12.2017
Annual Report FY 2017
2018-04-23 German
4SC AG: Phase II study of 4SC's resminostat in biliary tract cancer in Japan is initiated
Regulatory Filings
2018-04-19 English
4SC at AACR: Broadened clinical options for 4SC-202
Regulatory Filings
2018-04-17 English
4SC AG: Yakult Honsha recruits first Japanese patient in 4SC's pivotal RESMAIN study of resminostat in CTCL
Regulatory Filings
2018-04-11 English
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 17.05.2018 in Planegg-Martinsried mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2018-04-06 German
Annual financial report 2017
Annual Report FY 2017
2018-03-28 English
Annual financial report 2017
Annual Report FY 2017
2018-03-28 German
Yakult Honsha joins 4SC's pivotal RESMAIN study of resminostat in CTCL - 4SC receives milestone payment
Regulatory Filings
2018-03-27 English
4SC AG announces results for financial year 2017
Earnings Release FY 2017
2018-03-21 English
4SC AG: Conference call to be hosted on 21 March 2018 to present the financial report 2017
Report Publication Announcement
2018-03-15 English
Report Publication Announcement 2018
Report Publication Announcement
2018-03-13 English
Hinweis auf Jahresfinanzbericht vom 01.01.2017 bis zum 31.12.2017
Report Publication Announcement
2018-03-13 German
Datum:13.03.2018
Report Publication Announcement
2018-03-13 German
4SC AG: 8 upcoming conferences
Report Publication Announcement
2018-02-22 English
Positive DSMB safety review of 4SC's pivotal RESMAIN study of resminostat in CTCL
Regulatory Filings
2018-01-31 English
4SC AG strengthens patent protection for its Hedgehog/GLI signaling inhibitor 4SC-208
Regulatory Filings
2018-01-22 English
4SC AG: 11 upcoming conferences and investor events
Report Publication Announcement
2018-01-09 English